Analyze how specific documents activate the features of the SAE. Select a dataset, a run and a document to begin.
1518
Details List
Document Content
Ranitidine vs metoclopramide in the medical treatment of reflux esophagitis.
45 patients with symptomatic reflux esophagitis were randomly treated with either Ranitidine (150 mg b.i.d.) or Metoclopramide (10 mg t.i.d.) for six weeks. The severity of dyspeptic symptoms and the grade of endoscopic and histological esophagitis were assessed before and after treatment. Both drugs proved significantly effective in inducing symptomatic and endoscopic improvement, but Ranitidine appeared significantly superior in promoting disappearance or improvement of endoscopic esophagitis. Moreover Ranitidine was found to significantly reduce the severity of histological changes, whereas Metoclopramide was unable to do so.
Similar Documents
-
#807 0.523Limited diagnostic value of laryngopharyngeal les…
-
#859 0.487The relation between symptom improvement and gast…
-
#904 0.456Laparoscopic fundoplication: a natural extension …
-
#922 0.438EM523L, a nonpeptide motilin agonist, stimulates …
-
#494 0.411Conservative Treatment with Octreotide to Provide…